| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.12. | Treace Medical announces up to $175M debt facility | 1 | Seeking Alpha | ||
| 18.12. | Treace Medical Concepts, Inc.: Treace Medical Secures Up to $175 Million in Debt Financing | 85 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| 18.12. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 07.11. | Treace Medical Concepts Shares Drop 39% | - | RTTNews | ||
| 07.11. | Treace Medical plunges despite Q3 beat; BTIG downgrades on guidance cut | 1 | Seeking Alpha | ||
| TREACE MEDICAL CONCEPTS Aktie jetzt für 0€ handeln | |||||
| 07.11. | Morning Market Movers: Motorsport Games, Davis Commodities, Eledon Pharmaceuticals, Treace Medical Concepts See Big Swings | 824 | AFX News | BEIJING (dpa-AFX) - At 7:15 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 07.11. | Treace Medical Concepts stock downgraded to Neutral by BTIG on weak outlook | 1 | Investing.com | ||
| 07.11. | JPMorgan downgrades Treace Medical stock rating to Underweight amid market headwinds | 1 | Investing.com | ||
| 06.11. | Treace Medical steigert Umsatz in Q3 2025, schreibt aber weiterhin Verluste | 1 | Investing.com Deutsch | ||
| 23.10. | Treace Medical Concepts, Inc.: Treace to Report Third Quarter 2025 Financial Results on November 6, 2025 | 1 | GlobeNewswire (USA) | ||
| 10.09. | Treace Medical Concepts, Inc.: Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2025 American Orthopaedic Foot & Ankle Society Annual Meeting | 279 | GlobeNewswire (Europe) | PONTE VERDE, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| 03.09. | Truist Securities raises Treace Medical price target to $8 on new products | 3 | Investing.com | ||
| 08.08. | Treace Medical anticipates 7-10% revenue growth in 2025 while launching next-gen bunion solutions | 2 | Seeking Alpha | ||
| 05.08. | Treace Medical legt positive 4-Jahres-Studienergebnisse für Hallux-valgus-Verfahren vor | 1 | Investing.com Deutsch | ||
| 05.06. | Treace Medical Concepts, Inc.: Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty Bunion Technology | 295 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 18,780 | -1,93 % | Alignment Healthcare, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| BRIGHTSPRING HEALTH SERVICES | 37,750 | +0,05 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| NATERA | 233,64 | -0,81 % | Natera, Inc.: Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer | Multicenter, Signatera Genome-guided interventional trial will evaluate different treatment approaches in HR+/HER2- breast cancer Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA... ► Artikel lesen | |
| PROGYNY | 25,800 | +1,14 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 32,410 | -1,43 % | Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) | ||
| LIFESTANCE HEALTH GROUP | 7,130 | +0,56 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| HEARTFLOW | 29,830 | -2,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| ATRICURE | 40,330 | -0,54 % | XFRA NEW INSTRUMENTS AVAILABLE ON 18.09.2025 | The following instruments on XETRA do have their first trading 18.09.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 18.09.2025
Aktien
1 US64119N6085 Netskope Inc.
2 IE00BFY8C754... ► Artikel lesen | |
| GENEDX | 134,29 | -1,32 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| RXSIGHT | 10,930 | -4,62 % | RxSight, Inc. Announces Chief Financial Officer Transition | ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| PACS GROUP | 38,090 | +2,26 % | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| NUTEX HEALTH | 176,68 | +5,10 % | Nutex Health, Inc.: Nutex Health Responds To Short Seller Report | HOUSTON, Nov. 26, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), is aware of a short seller report issued on November... ► Artikel lesen | |
| ADAPTHEALTH | 10,240 | 0,00 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| CERIBELL | 21,300 | -0,56 % | Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution | SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| BETA BIONICS | 31,860 | +2,48 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen |